PAH
Showing 1 - 25 of 861
Lung in Pulmonary Artery Hypertension (PAH)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Healthy
- TSPO PET scan (11C-PBR28)
- (no location specified)
Feb 16, 2023
Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With
Not yet recruiting
- Pulmonary Arterial Hypertension
- +3 more
- 129Xe Hyperpolarized
-
Durham, North CarolinaDuke University Medical Center
Oct 23, 2023
Pulmonary Arterial Hypertension Trial (Sotatercept)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- (no location specified)
Apr 5, 2023
Pulmonary Arterial Hypertension Trial in Kansas City (Placebo, Seralutinib, Generic Dry Powder Inhaler)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Placebo
- +2 more
-
Kansas City, KansasUniversity of Kansas Medical Center
Jun 28, 2023
Repeatability of NT-proBNP Testing Using Laboratory and Point of
Active, not recruiting
- Pulmonary Artery Hypertension
- Exercise group
-
Sheffield, South Yorkshire, United KingdomPulmonary Vascular Disease Unit, Royal Hallamshire Hospital
Jun 14, 2022
Pulmonary Arterial Hypertension Trial in Cincinnati (Sotatercept)
Recruiting
- Pulmonary Arterial Hypertension
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center ( Site 1602)
Jan 31, 2023
Pulmonary Arterial Hypertension Trial in Nashville (mHealth Intervention, Usual Care)
Not yet recruiting
- Pulmonary Arterial Hypertension
- mHealth Intervention
- Usual Care
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 15, 2022
Prospective, Non-interventional, Multi-center,
Recruiting
- Hypertension, Pulmonary
- Riociguat (ADEMPAS, BAY63-2521)
-
Multiple Locations, JapanMany Locations
Aug 17, 2022
Hormonal, Metabolic, and Signaling Interactions in PAH
Recruiting
- Idiopathic Pulmonary Arterial Hypertension
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 23, 2022
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
Not yet recruiting
- Idiopathic Pulmonary Arterial Hypertension
- +2 more
- No Intervention
- (no location specified)
Jul 14, 2022
Pulmonary Arterial Hypertension (PAH) Trial in China (as per Physician's prescription)
Active, not recruiting
- Pulmonary Arterial Hypertension (PAH)
- as per Physician's prescription
-
Beijing, Beijing, China
- +6 more
Sep 14, 2022
Subjects Previously Administered HMI 102
Enrolling by invitation
- Phenylketonuria
- PAH Deficiency
- HMI-102
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Oxygen Deficiency, Pulmonary Arterial Hypertension, CTEPH Trial in Heidelberg (Oxygen)
Recruiting
- Oxygen Deficiency
- +2 more
-
Heidelberg, GermanyCentre for pulmonary hypertension of the Thoraxclinic at the Uni
Jul 12, 2022
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Los Angeles (Non-invasive hemodynamic
Enrolling by invitation
- Pulmonary Arterial Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
- Non-invasive hemodynamic measurements
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Nov 8, 2022
Pulmonary Arterial Hypertension Trial (Pulmonary artery denervation, Sham procedure)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Pulmonary artery denervation
- Sham procedure
- (no location specified)
Mar 30, 2022
Novel Index (PIMR) in PAH
Recruiting
- Pulmonary Hypertension
- Pulmonary Index of Microcirculatory Resistance
- Right Ventricle Index of Microcirculatory Resistance
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Apr 17, 2023
Pulmonary Arterial Hypertension PAH Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (ZMA001 (BC-NKA-20008),
Not yet recruiting
- Pulmonary Arterial Hypertension PAH
- ZMA001 (BC-NKA-20008)
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 3, 2023
Pulmonary Arterial Hypertension Trial in Nashville (ESR-specific PET scan)
Recruiting
- Pulmonary Arterial Hypertension
- ESR-specific PET scan
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 26, 2022
d Plasma Volume in Pulmonary Hypertension
Completed
- Pulmonary Arterial Hypertension
- +2 more
- (no location specified)
May 5, 2023
Pulmonary Arterial Hypertension Trial in Canada, Mexico, United States (V-Wave Interatrial Shunt)
Recruiting
- Pulmonary Arterial Hypertension
- V-Wave Interatrial Shunt
-
Los Angeles, California
- +4 more
Aug 29, 2022
Environmental Exposure Trial in Corvallis ([14C]-benzo[a]pyrene, Brussels sprouts before 50 ng dose, DIM supplement before 50 ng
Active, not recruiting
- Environmental Exposure
- [14C]-benzo[a]pyrene
- +2 more
-
Corvallis, OregonOregon State University
Apr 20, 2022
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
Recruiting
- Scleroderma
- Pulmonary Artery Hypertension
-
Baltimore, MarylandJohns Hopkins
Oct 20, 2022
Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension Trial in Beijing (Rituximab)
Not yet recruiting
- Systemic Lupus Erythematosus
- Pulmonary Arterial Hypertension
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 13, 2023